United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lupin healthcare (uk) ltd - raloxifene hydrochloride - oral tablet - 60mg

Singapore - English - HSA (Health Sciences Authority)

lotus international pte. ltd. - raloxifene hcl - tablet, film coated - 60 mg - raloxifene hcl 60 mg

Singapore - English - HSA (Health Sciences Authority)

novem pharma private limited - raloxifene hydrochloride (eqv. to raloxifene free base 56 mg) - tablet, film coated - 60.0 mg - raloxifene hydrochloride (eqv. to raloxifene free base 56 mg) 60.0 mg

United Kingdom - English - myHealthbox

pharmathen s.a - raloxifene hydrochloride - film-coated tablet - 60 mg - selective oestrogen receptor modulator - it is indicated for the treatment and prevention of osteoporosis in postmenopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated.

United Kingdom - English - myHealthbox

actavis group ptc ehf - raloxifene hydrochloride - film-coated tablet - 60 mg - selective oestrogen receptor modulator - it is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Malta - English - Medicines Authority

bristol laboratories limited - raloxifene hydrochloride - film-coated tablet - raloxifene hydrochloride 60 milligram(s) - sex hormones and modulators of the genital system

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - raloxifene hydrochloride - film-coated tablet - raloxifene hydrochloride 60 mg - sex hormones and modulators of the genital system

United Kingdom - English - myHealthbox

fair-med healthcare gmbh - raloxifene hydrochloride - film-coated tablets - 60mg - selective oestrogen receptor modulator - it is indicated for the treatment and prevention of osteoporosis in postmenopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated.

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - raloxifene hydrochloride - film coated tablet - 60 milligram - raloxifene

European Union - English - EMA (European Medicines Agency)

substipharm - raloxifene hydrochloride - osteoporosis, postmenopausal - sex hormones and modulators of the genital system, - evista is indicated for the treatment and prevention of osteoporosis in post-menopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. when determining the choice of evista or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits.